Rare diseases
Investigational molecules
Locations
Back to Greece1 004 clinical trials in Piraeus, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis
GreeceStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
GreeceStudy of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment
GreeceStudy of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer
GreeceStudy Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma
GreeceStudy on the Safety and Effectiveness of Crinecerfont for Children with Classic Congenital Adrenal Hyperplasia
GreeceStudy of Pegcetacoplan (APL-2) in Patients with Transplant-associated Thrombotic Microangiopathy After Stem Cell Transplantation
GreeceStudy on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia
GreeceStudy on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis
GreeceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments
GreeceStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
GreeceStudy of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy
GreeceThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, particularly in non-small cell lung cancer and novel therapeutic combinations. Studies include investigations of targeted therapies and immunotherapy approaches.
Innovative research combining standard treatments with new therapeutic agents to improve patient outcomes.
Research initiatives targeting heart failure prevention and stroke prevention in patients with atrial fibrillation. Studies evaluate new therapeutic approaches for managing cardiovascular risks.
Trials focusing on both preventive measures and treatment of established cardiovascular conditions.
Clinical investigations in multiple myeloma and related blood disorders, exploring combination therapies and novel treatment approaches for patients with various blood-related conditions.
Studies examining innovative therapeutic combinations for improved patient outcomes.
Research focusing on treating Crohn's Disease and other inflammatory conditions, evaluating new therapeutic options and combination treatments for better disease management.
Studies aimed at improving treatment outcomes in chronic inflammatory diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
